SRx Health Solutions Inc. (SRXH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SRx Health Solutions Inc. (SRXH) trades at $2.17 with AI Score 25/100 (Grade F). SRx Health Solutions Inc. is a Canadian integrated healthcare services provider focused on specialty healthcare. Market cap: $21.4M, Sector: Healthcare.
Price as of Jul 21, 2026 · Last analyzed: May 4, 2026Analyst Coverage for SRXH: SRXH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SRXH against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SRXH: 3/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
SRx Health Solutions Inc. (SRXH) Healthcare & Pipeline Overview
SRx Health Solutions Inc. delivers integrated specialty healthcare services throughout Canada, emphasizing customized solutions and patient-focused strategies. Operating in the drug manufacturing sector, SRx leverages technology to enhance wellness programs across all ten provinces, positioning itself as a comprehensive healthcare provider in a competitive market.
What Is the Investment Thesis for SRXH?
SRx Health Solutions Inc. presents a compelling investment thesis based on its integrated healthcare service model and focus on the specialty healthcare sector in Canada. With a gross margin of 20.1% and a significant profit margin of 302.1%, SRx demonstrates strong profitability potential. Key growth catalysts include expanding its customized healthcare solutions across all Canadian provinces and leveraging technology to enhance patient outcomes. The company's commitment to patient-centric care positions it favorably in a market increasingly focused on personalized healthcare solutions. However, potential risks include navigating the complex regulatory landscape of the Canadian healthcare system and competition from larger, more established players in the healthcare services market.
Based on FMP financials and quantitative analysis
SRXH Key Highlights
- Operates as an integrated healthcare services provider in Canada, offering comprehensive solutions across all ten provinces.
- Focuses on the specialty healthcare industry, providing customized services tailored to specific patient needs.
- Profit margin of 302.1% indicates strong profitability potential.
- Gross margin of 20.1% reflects efficient cost management in service delivery.
- Beta of 0.82 suggests lower volatility compared to the overall market.
Who Are SRXH's Competitors?
SRXH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MIRA MIRA Pharmaceuticals, Inc. | $0.92 | -4.16% | $38.7M | 47 |
| PTKFY PT Kalbe Farma Tbk. | $8.46 | -2.65% | $9.58M | 47 |
| CTOR Citius Oncology, Inc. | $0.61 | -11.45% | $56.7M | — |
| MAYNF Mayne Pharma Group Limited | $1.65 | -16.37% | $134M | 43 |
| CELG-RI Bristol-Myers Squibb Company Ce | $0.10 | +0.00% | $204M | 57 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $3.31 | +0.00% | $404M | 48 |
| LYPHF Luye Pharma Group Ltd. | $0.27 | -14.80% | $1.08B | 49 |
| PTKFF PT Kalbe Farma Tbk. | $0.04 | +11.41% | $2.03B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SRXH's Key Strengths?
- Integrated healthcare service model.
- Customized solutions tailored to patient needs.
- Strong industry knowledge and expertise.
- Presence across all ten Canadian provinces.
What Are SRXH's Weaknesses?
- Relatively small size with 11 employees.
- Limited brand recognition compared to larger competitors.
- Dependence on the Canadian healthcare system.
- Potential challenges in scaling operations.
What Could Drive SRXH Stock Higher?
- Expansion into new regions within Canada to increase market share.
- Integration of new technologies to enhance service delivery and patient outcomes.
- Strategic partnerships with pharmaceutical companies to expand service offerings.
What Are the Key Risks for SRXH?
- Financial-distress signal — its Altman Z-Score of -1.81 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory changes in the Canadian healthcare system impacting operations.
- Economic downturn affecting healthcare spending and patient demand.
- Competition from larger, more established healthcare providers.
- Technological disruptions rendering existing solutions obsolete.
What Are the Growth Opportunities for SRXH?
- Expansion Across Canadian Provinces: SRx Health Solutions Inc. has the opportunity to further expand its reach across all ten Canadian provinces. By establishing a stronger presence in underserved regions, SRx can tap into new markets and increase its patient base. The Canadian healthcare market is projected to reach $300 billion by 2028, offering substantial growth potential for SRx. This expansion can be achieved through strategic partnerships with local healthcare providers and targeted marketing campaigns.
- Technological Integration: Integrating advanced technologies, such as telehealth platforms and AI-driven diagnostic tools, can significantly enhance SRx's service offerings. The global telehealth market is expected to reach $55 billion by 2027, indicating a strong demand for remote healthcare solutions. By leveraging technology, SRx can improve patient access, reduce costs, and enhance the overall quality of care. This includes developing user-friendly mobile applications and secure data management systems.
- Customized Healthcare Solutions: SRx Health Solutions Inc.'s focus on customized healthcare solutions provides a significant competitive advantage. By tailoring its services to meet the specific needs of individual patients, SRx can improve patient outcomes and increase customer satisfaction. The personalized medicine market is projected to reach $2.4 billion by 2028, reflecting a growing demand for individualized treatment plans. This approach can be further enhanced by incorporating genetic testing and personalized medication management.
- Strategic Partnerships: Forming strategic partnerships with pharmaceutical companies and healthcare providers can expand SRx's service offerings and market reach. Collaborating with pharmaceutical companies can provide access to new medications and treatment protocols, while partnering with healthcare providers can enhance patient referrals and integrated care pathways. These partnerships can also facilitate the development of innovative healthcare solutions and improve the overall efficiency of the healthcare system.
- Focus on Preventative Care: Expanding its focus on preventative care can help SRx reduce healthcare costs and improve patient outcomes. By offering wellness programs, health screenings, and early intervention services, SRx can help patients manage their health proactively and prevent the onset of chronic diseases. The preventative healthcare market is projected to reach $600 billion by 2027, indicating a growing demand for proactive health management solutions. This includes offering educational resources and personalized health coaching.
What Opportunities Does SRXH Have?
- Expansion into underserved regions of Canada.
- Integration of advanced technologies to enhance service offerings.
- Strategic partnerships with pharmaceutical companies and healthcare providers.
- Focus on preventative care and wellness programs.
What Threats Does SRXH Face?
- Competition from larger, more established healthcare providers.
- Regulatory changes in the Canadian healthcare system.
- Economic downturn impacting healthcare spending.
- Potential for technological disruptions.
What Are SRXH's Competitive Advantages?
- Integrated healthcare service model provides a comprehensive approach to patient care.
- Customized solutions cater to specific patient needs, enhancing customer satisfaction.
- Strong industry knowledge and technological integration improve service delivery.
- Established presence across all ten Canadian provinces provides a broad market reach.
What Does SRXH Do?
SRx Health Solutions Inc. is a Canadian integrated healthcare services provider dedicated to the specialty healthcare industry. The company was founded with the vision of delivering comprehensive, integrated, and customized healthcare services across all ten Canadian provinces. SRx Health Solutions combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians. Their services span a broad spectrum of specialty healthcare needs, ensuring that patients receive tailored care that addresses their specific conditions and requirements. SRx Health Solutions operates as a key player in the Canadian healthcare landscape, focusing on delivering patient-centric solutions. By integrating technology and deep industry expertise, SRx is committed to enhancing the quality and accessibility of specialty healthcare services across Canada. The company's comprehensive approach and dedication to patient wellness have established it as a trusted partner for healthcare providers and patients alike.
What Products and Services Does SRXH Offer?
- Provides integrated healthcare services in Canada.
- Offers customized specialty healthcare solutions.
- Operates across all ten Canadian provinces.
- Focuses on improving patient wellness through tailored strategies.
- Integrates industry knowledge and technology to enhance healthcare delivery.
- Offers comprehensive healthcare services to address diverse patient needs.
How Does SRXH Make Money?
- Generates revenue by providing customized healthcare services to patients.
- Partners with healthcare providers and pharmaceutical companies to expand service offerings.
- Focuses on delivering integrated healthcare solutions to improve patient outcomes.
What Industry Does SRXH Operate In?
SRx Health Solutions Inc. operates within the competitive Canadian healthcare services market, which is characterized by increasing demand for specialized and integrated healthcare solutions. The industry is driven by an aging population and a growing prevalence of chronic diseases. SRx competes with other healthcare providers and pharmaceutical companies, differentiating itself through its patient-centric approach and customized service offerings. The Canadian healthcare market is heavily regulated, with provincial governments playing a significant role in funding and oversight. SRx's ability to navigate this regulatory landscape and deliver cost-effective solutions will be critical to its success.
Who Are SRXH's Key Customers?
- Individual patients seeking specialty healthcare services.
- Healthcare providers looking to enhance their service offerings.
- Pharmaceutical companies seeking to partner on healthcare solutions.
F-Score 2/9Financial Health
SRx Health Solutions Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.81 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Its free cash flow yield is -91.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.72 indicates the company holds enough short-term assets to cover its near-term obligations.
SRx Health Solutions Inc. (SRXH) Valuation Context
Valued at $21.4M, SRXH is classified as a micro-cap stock. Relative to its peer group, SRXH's quantitative score of 25/100 is below the peer average of 49/100.
FY2026 estForward Outlook
Wall Street analysts project SRx Health Solutions Inc. revenue of about $132.5M for fiscal 2026, with EPS near $110.45.
Net buyingInsider Activity
Over the past six months, SRx Health Solutions Inc. insiders filed 2 SEC Form 4 transactions — 0 sales and 2 purchases. On net that is roughly 248K shares acquired (about $129K) — insiders putting money in tends to read as conviction.
SRXH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in SRx Health's growth potential, signaling a strong belief in the company's future.
- Community sentiment has shifted positively, with many discussions highlighting the company's innovative health solutions and their market relevance.
- Analysts are increasingly recognizing SRx Health's strategic partnerships, which could enhance their competitive edge in the healthcare sector.
- The ongoing demand for health solutions amid changing regulations indicates a favorable environment for SRx Health's offerings.
Bear Case
- Despite recent positive sentiment, some investors are concerned about the overall volatility in the healthcare sector, which could impact SRx Health's stability.
- There are discussions about potential regulatory challenges that could pose risks to SRx Health's business model and operational efficiency.
- Community feedback includes skepticism regarding the company's ability to scale its operations effectively in a competitive landscape.
- Recent market developments have raised questions about the sustainability of SRx Health's growth trajectory, leading to caution among some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SRXH Latest News
-
12 Consumer Staples Stocks Moving In Friday's Intraday Session
benzinga · Jul 10, 2026
-
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
globenewswire.com · Jul 10, 2026
-
SRX Global Shares Halted On Circuit Breaker To The Upside, Stock Now Up 37.06%
benzinga · Jul 9, 2026
-
SRX Global Approves $20 Million Stock Buyback Program
MT Newswires · Jul 9, 2026
SRXH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SRXH.
Price Targets
Wall Street price target analysis for SRXH.
SRXH MoonshotScore
What does this score mean?
The MoonshotScore rates SRXH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
12 Consumer Staples Stocks Moving In Friday's Intraday Session
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
SRX Global Shares Halted On Circuit Breaker To The Upside, Stock Now Up 37.06%
SRX Global Approves $20 Million Stock Buyback Program
Leadership: Kent Cunningham
CEO
Kent Cunningham is the CEO of SRx Health Solutions Inc. He brings extensive experience in the healthcare industry, with a focus on developing and implementing integrated healthcare solutions. Cunningham has a background in healthcare management and a proven track record of driving growth and innovation. His expertise lies in creating patient-centric strategies and leveraging technology to improve healthcare delivery. He is committed to enhancing the wellness of Canadians through SRx's comprehensive service offerings.
Track Record: Under Kent Cunningham's leadership, SRx Health Solutions Inc. has expanded its presence across all ten Canadian provinces and has strengthened its focus on customized healthcare solutions. Cunningham has overseen the integration of new technologies to enhance service delivery and has fostered strategic partnerships with pharmaceutical companies and healthcare providers. His leadership has been instrumental in driving the company's growth and establishing it as a trusted provider of specialty healthcare services.
SRx Health Solutions Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for SRXH?
SRXH holds an AI Score of 25/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. SRx Health Solutions Inc. is a Canadian integrated healthcare services provider focused on specialty healthcare. They offer customized solutions across all Canadian provinces, leveraging technology …
What does SRx Health Solutions Inc. do?
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.
What do analysts say about SRXH stock?
As of 2026-05-04, SRXH has a market capitalization of $21.4M. The company's profit margin is 302.1%, and the gross margin is 20.1%. The beta is 0.82, indicating lower volatility compared to the market. Given the lack of analyst coverage and the company's small size, traditional valuation metrics may not fully capture its growth potential.
What are the main risks for SRXH?
The main risks for SRx Health Solutions Inc. include regulatory changes in the Canadian healthcare system, which could impact its operations and profitability. Competition from larger, more established healthcare providers poses a significant challenge. An economic downturn could reduce healthcare spending and patient demand. Additionally, technological disruptions could render existing solutions obsolete, requiring continuous innovation and adaptation to maintain a competitive edge.
How does SRx Health Solutions Inc. navigate regulatory approval processes?
SRx Health Solutions Inc. operates within the highly regulated Canadian healthcare system, requiring adherence to provincial and federal regulations. The company maintains a dedicated regulatory affairs team that monitors changes in healthcare policies and ensures compliance with all applicable laws and guidelines. SRx works closely with regulatory bodies to obtain necessary approvals for its services and technologies.
What is SRx Health Solutions Inc.'s competitive advantage in the Canadian healthcare market?
SRx Health Solutions Inc.'s competitive advantage lies in its integrated healthcare service model and focus on customized solutions. By offering comprehensive services across all ten Canadian provinces, SRx provides a seamless and convenient experience for patients. The company's patient-centric approach and tailored treatment plans enhance customer satisfaction and improve patient outcomes.
What are the key factors to evaluate for SRXH?
SRx Health Solutions Inc. (SRXH) holds an AI score of 25/100 (low). Not financial advice.
How frequently does SRXH data refresh on this page?
SRXH's price was last updated on Jul 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SRXH's recent stock price performance?
SRx Health Solutions Inc. (SRXH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated healthcare service model. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company data and may be subject to change.
- Financial metrics are based on the most recent available data.